Efficiency of anti-vascular endothelial growth factor drug switch in patients who did not respond to a series of bevacizumab injections.

Indian J Ophthalmol · 2026 · PMC13225335 · PMID 41385282

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

As previously mentioned, the CMT difference between D1 and D2 did not reach statistical significance, raising questions regarding the necessity of switching between anti-VEGF agents in cases of persistent DME.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.